Rénata Ursu

2.7k total citations · 1 hit paper
39 papers, 1.2k citations indexed

About

Rénata Ursu is a scholar working on Genetics, Oncology and Neurology. According to data from OpenAlex, Rénata Ursu has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 14 papers in Oncology and 11 papers in Neurology. Recurrent topics in Rénata Ursu's work include Glioma Diagnosis and Treatment (18 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and CAR-T cell therapy research (6 papers). Rénata Ursu is often cited by papers focused on Glioma Diagnosis and Treatment (18 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and CAR-T cell therapy research (6 papers). Rénata Ursu collaborates with scholars based in France, Switzerland and Netherlands. Rénata Ursu's co-authors include Alain Carpentier, Cathérine Belin, Stefania Cuzzubbo, Jennifer Doridam, Célèste Lebbé, Annick Tibi, Olivier Chinot, Philippe Métellus, Florence Laigle–Donadey and Olivier Bailon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Rénata Ursu

35 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature

2017 397 citations Stefania Cuzzubbo, Jennifer Doridam et al. European Journal of Cancer profile →

Peers

Countries citing papers authored by Rénata Ursu

Since Specialization

Citations

This map shows the geographic impact of Rénata Ursu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rénata Ursu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rénata Ursu more than expected).

Fields of papers citing papers by Rénata Ursu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rénata Ursu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rénata Ursu. The network helps show where Rénata Ursu may publish in the future.

Co-authorship network of co-authors of Rénata Ursu

This figure shows the co-authorship network connecting the top 25 collaborators of Rénata Ursu. A scholar is included among the top collaborators of Rénata Ursu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rénata Ursu. Rénata Ursu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Baseline Cognitive and Neurological Status Does Not Modify the Occurrence of ICANS in CAR T‐Cell Therapy for Aggressive B‐Cell Lymphoma 2025 ·European Journal of Neurology ·Rénata Ursu, (unknown), Roberta Di Blasi, Cathérine Belin, Stefania Cuzzubbo, (unknown), (unknown), (unknown), Amani Ouedrani, Catherine Thiéblemont, Sophie Caillat‐Zucman, Alain Carpentier	1
2	Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric study 2024 ·Neuro-Oncology ·Laura Rozenblum, Caroline Houillier, Amandine Baptiste, Carole Soussain, Véronique Edeline, (unknown), M. Soret, (unknown), Lise Willems, Sylvain Choquet, Rénata Ursu, Damien Galanaud, Lisa Belin, Khê Hoang‐Xuan, Aurélie Kas	2
3	Unveiling the Clinical and Imaging Signatures of Intravascular Lymphoma of the Central Nervous System: A Multicentric Cohort Study 2024 ·Annals of Neurology ·(unknown), (unknown), Caroline Houillier, Rénata Ursu, Carole Soussain, Mehdi Touat, Antoine Guéguen, Benoît De Renzis, Kévin Bigaut, Guido Ahle, (unknown), (unknown), Lucie Obéric, (unknown), (unknown), Cécile Moluçon‐Chabrot, Khê Hoang‐Xuan, Hugues Chabriat, Stéphanie Guey	2
4	Primary central nervous system lymphoma of the spinal cord: A LOC network cohort study 2024 ·Revue Neurologique ·(unknown), Guido Ahle, Émeline Tabouret, Roch Houot, Fabrice Jardin, Hervé Ghesquières, Anna Schmitt, Jérôme Paillassa, Sylvain Choquet, (unknown), Rénata Ursu, Lucia Nichelli, (unknown), Bertrand Mathon, Laura Rozenblum, Karima Mokhtari, Khê Hoang‐Xuan, Caroline Houillier	0
5	P06.17.A OPTIC NEUROPATHY RELATED TO IMMUNE CHECKPOINT INHIBITORS: A CASE SERIES 2023 ·Neuro-Oncology ·Stefania Cuzzubbo, (unknown), Barouyr Baroudjian, Rénata Ursu, Célèste Lebbé, (unknown), Alain Carpentier	0
6	Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study 2023 ·Annals of Hematology ·Jean‐François Dufour, Sylvain Choquet, Khê Hoang‐Xuan, Anna Schmitt, Guido Ahle, Roch Houot, Luc Taillandier, Rémy Gressin, Olivier Casasnovas, JP Marolleau, Jérôme Tamburini, (unknown), (unknown), Jérôme Paillassa, Emmanuel Gyan, Adrien Chauchet, Rénata Ursu, Aurélie Kas, Carole Soussain, Caroline Houillier	2
7	[18F]FDG PET-MRI provides survival biomarkers in primary central nervous system lymphoma in the elderly: an ancillary study from the BLOCAGE trial of the LOC network 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Laura Rozenblum, Damien Galanaud, Caroline Houillier, Carole Soussain, Amandine Baptiste, Lisa Belin, Véronique Edeline, (unknown), M. Soret, (unknown), Lise Willems, Sylvain Choquet, Rénata Ursu, Khê Hoang‐Xuan, Aurélie Kas	8
8	Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy 2022 ·Neurology ·Rénata Ursu, Didier Maillet, Cathérine Belin, Christine Moroni, Stefania Cuzzubbo, (unknown), (unknown), (unknown), Roberta Di Blasi, Catherine Thiéblemont, Alain Carpentier	20
9	Predictive factors of human cytomegalovirus reactivation in newly diagnosed glioblastoma patients treated with chemoradiotherapy 2021 ·Journal of NeuroVirology ·Rénata Ursu, Jennifer Doridam, (unknown), (unknown), Cathérine Belin, Stefania Cuzzubbo, (unknown), Ségolène Brichler, C Lévy-Piedbois, Alain Carpentier	3
10	1673MO The GCO-002 CACOVID-19 cohort: A French nationwide multicenter study of COVID-19 infected cancer patients and consequences on cancer management 2020 ·Annals of Oncology ·Astrid Lièvre, Anthony Turpin, Isabelle Laure Ray-Coquard, Karine Le Malicot, Juliette Thariat, Guido Ahle, Romain Mathiéu, (unknown), D. Debieuvre, Anthony Canellas, (unknown), Raphaël Colle, (unknown), Luigi Mansi, Jean Bourhis, Philippe Gorphe, Rénata Ursu, (unknown), Gérard Zalcman, Olivier Bouché	1
11	1721P Prolonged positive SARS-CoV-2 RT-PCR in cancer outpatients requires specific reorganization of cancer centres 2020 ·Annals of Oncology ·(unknown), Rénata Ursu, Jérôme LeGoff, (unknown), (unknown), Stéphanie Harel, Bruno Royer, Marie Sébert, M. Jachiet, Célèste Lebbé, Clément Bonnet, Pauline Brice, Pierre Fenaux, Benoît Plaud, Thomas Aparicio	1
12	Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study 2019 ·European Journal of Cancer ·Rénata Ursu, Laure Thomas, Dimitri Psimaras, Olivier Chinot, Émilie Le Rhun, Damien Ricard, M. Charissoux, Stefania Cuzzubbo, (unknown), Véronique Quillien, Khê Hoang‐Xuan, François Ducray, Jean-Jacques Portal, Annick Tibi, Emmanuel Mandonnet, C Lévy-Piedbois, Éric Vicaut, Alain Carpentier	13
13	Evolution of the Karnosky Performance Status throughout life in glioblastoma patients 2015 ·Journal of Neuro-Oncology ·Adama Sacko, (unknown), (unknown), (unknown), (unknown), Cathérine Belin, Emmanuel Mandonnet, Rénata Ursu, Jennifer Doridam, Irène Coman, C Lévy-Piedbois, Alain Carpentier	39
14	Initial Experience Using Awake Surgery for Glioma 2015 ·Neurosurgery ·Emmanuel Mandonnet, Philip C. De Witt Hamer, (unknown), Ian R. Whittle, Anne-Laure Bernat, Damien Bresson, (unknown), S. Bouazza, Rénata Ursu, Alain Carpentier, Bernard George, Sébastien Froelich	67
15	Steroid‐sparing effects of angiotensin‐ II inhibitors in glioblastoma patients 2012 ·European Journal of Neurology ·Alain Carpentier, Daniela Ferrari, Olivier Bailon, Rénata Ursu, Claire Banissi, Anne‐Laure Dubessy, Cathérine Belin, Christine Lévy	28
16	Immunotherapeutic Approach with Oligodeoxynucleotides Containing CpG Motifs (CpG-ODN) in Malignant Glioma 2012 ·Advances in experimental medicine and biology ·Rénata Ursu, Alain Carpentier	16
17	Superficial siderosis of the central nervous system: a rare cause of dementia with therapeutic consequences 2012 ·Age and Ageing ·Anne‐Laure Dubessy, Rénata Ursu, Didier Maillet, (unknown), (unknown), Alain Carpentier, Cathérine Belin	7
18	Steroid requirements during radiotherapy for malignant gliomas 2010 ·Journal of Neuro-Oncology ·(unknown), Christine Lévy, Alyette Duquesne, Rénata Ursu, Olivier Bailon, Irène Coman, Cathérine Belin, Alain Carpentier	24
19	Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study 2010 ·Neuro-Oncology ·Alain Carpentier, Philippe Métellus, Rénata Ursu, Sarah Zohar, F. Lafitte, Maryline Barrié, Yuxia Meng, Martín Richard, Christophe Parizot, Florence Laigle–Donadey, Guy Gorochov, Dimitri Psimaras, Marc Sanson, Annick Tibi, Olivier Chinot	163
20	Méningite chronique à méningocoque de l’adulte 2008 ·Revue Neurologique ·Rénata Ursu, (unknown), Nadia Valin, (unknown), (unknown), J. Delattre	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact